Quantitative Sensory Test 1 for Chronic Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Johns Hopkins Medical Institutions, Baltimore, MDChronic Pain+1 MoreQuantitative Sensory Test 1 - DiagnosticTest
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether a new assessment of neurosensory phenotyping can predict which patients with chronic pancreatitis will respond best to endoscopic therapy or surgery.

Eligible Conditions
  • Chronic Pain
  • Chronic Pancreatitis

Treatment Effectiveness

Study Objectives

1 Primary · 16 Secondary · Reporting Duration: 3, 6, and 12 months

12 months
Mean reported daily opioid dose for patients using prescription opioids at time of assessment
Number of patients using prescription opioids for pain control at time of assessment
Pain relief of ≥30%
12 months after intervention
Pain
12 months after intervention.
Pain
Month 12
Patient Global Impression of Change (PGIC) Scale
Month 12
Change from baseline on the Comprehensive Pain Assessment Tool for Pancreatitis Short Form (COMPAT-SF)
Change from baseline on the European Organization for the Research and Treatment of Cancer Quality(EORTC) of Life Questionnaire (QLQ) Core 30 (C30)
Change from baseline on the Hospital Anxiety and Depression Scale (HADS)
Change from baseline on the Modified Brief Pain Inventory Short Form (mBPI-SF)
Change from baseline on the Pain Catastrophizing Scale (PCS)
Change from baseline on the Patient Reported Outcomes Measurement Information System (PROMIS) Global Health Scale
Change from baseline on the Patient Reported Outcomes Measurement Information System (PROMIS) Neuropathic Pain Scale
Change from baseline on the Patient Reported Outcomes Measurement Information System (PROMIS) Nociceptive Pain Scale
Change from baseline on the Patient Reported Outcomes Measurement Information System (PROMIS) Pain Interference Scale
at 12 months.
Change from baseline in Single-question NRS score
six months post procedure
Average Pain Score

Trial Safety

Trial Design

1 Treatment Group

Pancreatic Quantitative Sensory Testing (P-QST)
1 of 1

Experimental Treatment

150 Total Participants · 1 Treatment Group

Primary Treatment: Quantitative Sensory Test 1 · No Placebo Group · N/A

Pancreatic Quantitative Sensory Testing (P-QST)Experimental Group · 3 Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, Quantitative Sensory Test 3 · Intervention Types: DiagnosticTest, DiagnosticTest, DiagnosticTest

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 3, 6, and 12 months

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,634 Previous Clinical Trials
16,307,384 Total Patients Enrolled
15 Trials studying Chronic Pain
128,773 Patients Enrolled for Chronic Pain
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,185 Previous Clinical Trials
4,089,679 Total Patients Enrolled
5 Trials studying Chronic Pain
1,218 Patients Enrolled for Chronic Pain
Anna Evans Phillips, MD, MSPrincipal InvestigatorUniversity of Pittsburgh

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are an adult with a pancreatic condition called chronic pancreatitis and your doctor has recommended a procedure to help relieve pain caused by blockages in your pancreatic duct.
You have undergone a procedure called Endoscopic Retrograde Cholangiopancreatography (ERCP), which involves removing stones or placing stents in your pancreatic duct. You may have also received treatment through a procedure called Extracorporeal Shock Wave Lithotripsy (ESWL).
You have had certain types of surgeries, including the Frey and Puestow operations.

Frequently Asked Questions

How many participants are currently enrolled in this research project?

"Indeed, the information provided on clinicaltrials.gov affirms that this medical investigation is currently recruiting patients. The trial was initially posted on April 1st 2022 and has been revised more recently on January 17th of the same year. A total of 150 volunteers need to be enrolled from two locations." - Anonymous Online Contributor

Unverified Answer

Are there any vacancies open to partake in this clinical investigation?

"According to the clinicaltrials.gov registry, this experiment is actively seeking potential subjects. The trial was initially created on April 1st 2022 with a recent update on January 17th 2021." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.